Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 April 1993 | Volume 118 Issue 7 | Pages 504-510
Objectives: To determine the incidence of and risk factors for perioperative myocardial infarction with noncardiac surgery and to test the accuracy of a risk stratification system.
Design: Prospective cohort study.
Setting: A large urban Veterans Affairs hospital.
Participants: A total of 1487 men older than 40 years undergoing major, nonemergent, noncardiac operations.
Measurements: Infarction was established by at least two of the following: development of new Q waves, typical change in creatine kinase MB, and positive technetium pyrophosphate scintigraphy. Patients were stratified preoperatively into high-, intermediate-, low-, and negligible-risk strata based on clinical markers corresponding to different levels of coronary artery disease prevalence.
Main Results: Patients with coronary disease (high-risk stratum) had a 4.1% incidence of infarction (13 of 319; 95% CI, 1.8% to 6.4%); patients with peripheral vascular disease but no evidence of coronary disease (intermediate-risk stratum) had a 0.8% incidence (2 of 260, upper bound of CI, 2.0%); patients with high atherogenic risk factor profiles but no clinical atherosclerosis (low-risk stratum) had a 0% incidence (0 of 256, upper bound of CI, 1.2%). No cardiac deaths occurred in 652 men who had no atherosclerosis and low atherogenic risk factor profiles (the negligible-risk stratum). Factors independently associated with infarction included age more than 75 years (adjusted odds ratio, 4.77; CI, 1.17 to 19.41), signs of heart failure on the preoperative examination (adjusted odds ratio, 3.31; CI, 0.96 to 11.38), coronary disease (adjusted odds ratio, 10.39; CI, 2.27 to 47.46), and a planned vascular operation (adjusted odds ratio, 3.72; CI, 1.12 to 12.37).
Conclusions: Coronary artery disease is the major risk factor for perioperative infarction. The stratification scheme identifies subsets of patients with different risks, and finer within-stratum distinctions can be made using additional variables.
Uncertainty about the true incidence of perioperative infarction has important consequences. Many patients facing noncardiac surgery undergo extensive testing to assess their risk for having a cardiac complication. In patients perceived to be at high risk, invasive procedures ranging from pulmonary artery catheterization [13] to prophylactic coronary artery bypass [14-16] are recommended to reduce the risk. However, if the true incidenceand hence a given individual's riskfor perioperative infarction is not known, we cannot be sure that the interventions we recommend do not carry risks that outweigh the adverse consequences of a perioperative infarction with the planned procedure.
When we began this study, the most commonly used approach to estimating an individual's risk for perioperative cardiac complications was that of Goldman and colleagues [5] (later modified by Detsky and coworkers [10]). Goldman's cardiac risk index is based on nine differentially weighted factors and predicts the likelihood that any of three complicationsinfarction, pulmonary edema, and ventricular tachycardiamay occur. Grouping these together limits the index's usefulness. They differ somewhat etiologically, require different approaches for detection, are treated differently, and have different implications for longevity and functional status. More importantly, they require different approaches to prevention.
We thought that the debate about prevention of perioperative infarction needed more precise data on incidence, and our main objective in performing the present study was to provide that data. We also wanted to evaluate the performance of a preoperative risk stratification scheme that classified patients according to their probability of having coronary artery disease and to determine whether other clinical factors in addition to coronary artery disease are associated with an increased risk for perioperative infarction.
Three kinds of patients were studied: active participants, who consented to a preoperative and postoperative evaluation protocol (n = 512); chart review patients, who either declined the evaluation protocol (n = 184) or had surgery before they could be approached about participating (n = 139); and negligible-risk patients (n = 652) whose risk for perioperative infarction was extremely low. Because of resource constraints, negligible-risk patients were not asked to participate, and the only postoperative data collected on them were the occurrence and cause of death.
Preoperative Risk Stratification
The risk stratification scheme tested prospectively in this study is based on the premise that because autoregulatory mechanisms are able to maintain myocardial perfusion in the normal heart over a wide range of conditions, coronary atherosclerosis is a necessary precondition for perioperative infarction. Information from the history, examination, and clinical record allows the scheme to assign patients preoperatively into four risk strata for perioperative infarction, representing different levels of prevalence of coronary atherosclerosis, taking into account that significant coronary atherosclerosis can exist in a subclinical form. We projected that the incidence of infarction would decrease down the strata as the prevalence of coronary atherosclerosis decreased because a smaller proportion of the stratum would be at risk.
The high-risk stratum included patients almost certain to have coronary atherosclerosis: those with a history of infarction or electrocardiographic (ECG) evidence of such according to the Minnesota Code [17], typical angina (in whom the likelihood of coronary disease is 90% [18]), angiographically documented significant coronary disease (> 50% reduction in the left main or a 70% or more reduction in the right, left anterior descending, or left circumflex arteries), or a history of coronary bypass surgery. The intermediate-risk stratum included patients without evidence of coronary atherosclerosis but with atherosclerosis elsewhere (the prevalence of significant occult coronary disease in such patients is about 30% [14]): those with a history of stroke or transient ischemic attacks, a history of peripheral vascular surgery for atherosclerosis (or whose scheduled operation was such), claudication, or carotid bruit. Patients with atypical chest pain were also placed here because about half of these patients have coronary disease [19]. The low-risk stratum included patients who had no clinical atherosclerosis but who had a high atherogenic risk factor profile (sex, age, cigarette smoking, blood pressure, cholesterol, glucose tolerance, and ECG abnormalities), that is, at least a 15% likelihood of a cardiac event within 6 years, based on the Framingham probability tables [19] in the Coronary Risk Handbook [20]. A small proportion of such patients had significant, although occult, coronary disease [21]. We also placed in the low-risk stratum men older than 75 years without clinical atherosclerosis regardless of their likelihood of a future cardiac event. Patients who met none of the above conditions were, by definition, in the negligible-risk stratum. Using a process of elimination from high- to negligible-risk, stratifying a patient took about 10 minutes. Only one criterion was necessary to place a patient in a stratum. Figure 1 illustrates how the patients were distributed among the strata. ARTICLE
The Incidence of Perioperative Myocardial Infarction in Men Undergoing Noncardiac Surgery
Reported rates of perioperative myocardial infarction in patients undergoing noncardiac surgery vary widely. In healthy persons, the incidence is consistently less than 1% [1-4], but in persons with heart disease or risk factors for heart disease rates range from 3% to 17% [4-9]. Some of the variation relates to the operations studied; minor surgery has the lowest rates [10, 11] and vascular surgery has the highest [9, 12]. A substantial amount of the disparity, however, results from methodologic issues, in particular the way in which patients were selected for study, the sensitivity and specificity of the tests used to diagnose infarction, and whether diagnostic tests were uniformly applied in the postoperative period.
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
This study was performed at the Houston Veterans Affairs Medical Center from July 1987 through December 1989. The participants were 1487 consecutive men age 40 years or older who had major elective or urgent noncardiac surgery. Women were excluded; they account for less than 1% of operations at our hospital. The study was approved by the relevant institutional review boards.
|
Preoperative Evaluation and Intraoperative and Postoperative Data
Active participants had a preoperative history, cardiovascular system review, and examination by an investigator. A standard questionnaire was used to detect angina and intermittent claudication [22], and standardized questions were used to detect transient ischemic attacks. Serum total creatine kinase and its MB isoenzyme were measured, and an ECG was obtained. No other preoperative cardiac tests were part of the study protocol. Standard cardiac tests were obtained at the discretion of the surgeon, but during the study years dipyridamole thallium scintigraphy was not performed at our hospital. Chart review patients were slightly older and had a higher preoperative Goldman cardiac risk index [5], but they had a lower prevalence of coronary disease (Table 1).
|
Active participants had an ECG, total creatine kinase, and MB measurement between 0600 and 0800 on the first three postoperative days. Operative data were obtained from anesthesia records. Sustained hypotension (a 30% decrease in the mean arterial pressure sustained for more than 10 minutes) was noted because it is associated with perioperative infarction [4, 6, 8, 23]. Data on postoperative cardiovascular problems were obtained from the chart and, in active participants, from investigators' visits.
Total creatine kinase values were quantitated enzymatically and the MB isoenzyme was quantitated immunochemically using Roche reagents (Roche Diagnostic Systems, Nutley, New Jersey). Creatine kinase levels are elevated by surgical skeletal muscle trauma, but the MB isoenzyme retains specificity for myocardial damage after noncardiac surgery [24]. In patients with myocardial necrosis, creatine kinase MB almost always remains elevated for more than 24 hours [25]. A certified coder analyzed all ECGs using the Minnesota Code [18], a standardized system of waveform measurement and classification that controls interobserver variability and interpretation bias. A bias exists toward underdiagnosis of infarction in chart review patients because we had to rely on diagnostic tests ordered at the surgeon's discretion.
Diagnostic Criteria for Perioperative Myocardial Infarction
"Perioperative" denotes the time from arrival in the operating suite to hospital discharge. A diagnosis of infarction was based on new postoperative Q-QS patterns (62% sensitivity and 88% specificity for infarction [26]) and serial changes in creatine kinase MB levels (the immunochemical assay has 94% sensitivity and 95% specificity for acute infarction [27]). Patients whose ECGs or enzymes were equivocal underwent technetium pyrophosphate infarct scintigraphy. Infarction was diagnosed in four patients with equivocal ECGs or enzymes whose scintigram was positive using the criteria of Righetti and colleagues [28].
Statistical Analysis
The association between potential predictors and perioperative infarction was explored using the chi-square test and relative risk for categorical variables and the t-test for continuous variables. Logistic regression was used to test for independence among predictors. Highly correlated variables were not included in the same model. Because our aim was to create a clinical prediction model that would be helpful to clinicians performing preoperative assessments, only variables that could be known preoperatively were tested in the models. Variables were selected for testing based on theoretical connections with infarction rather than exclusively on univariate significance levels. Because of the low event rate, a level of 0.15 was used to remove variables from the models. Goodness of fit was assessed using the log likelihood chi-square statistic [29].
Because the results of the analysis of active participants alone are similar to those of the combined group of active participants and chart review patients, the groups are combined in the analysis.
Results
|
|---|
|
|
|---|
The overall incidence of perioperative myocardial infarction in active participants was 1.7% (8 of 512; 95% CI, 0.4% to 2.7%). Despite the potential bias toward underdiagnosis of infarction in chart review patients, incidence in this group was 2.2% (7 of 323; CI, 0.4% to 3.9%). Incidence in both groups combined was 1.8% (15 of 835; CI, 0.8% to 2.8%). The incidence of myocardial infarction and other perioperative complications is given in Table 2.
|
The preoperative risk stratification scheme partitioned the patients into groups with a decreasing incidence (Table 3). Patients with coronary artery disease (the high-risk stratum) had a 4.1% incidence (13 of 319; CI, 1.8% to 6.4%). Patients with peripheral vascular disease but no evidence of coronary atherosclerosis (intermediate-risk) had a 0.8% incidence (2 of 260; upper bound of CI, 2.0%). No infarctions were observed in 256 patients who had high atherogenic risk factor profiles but no clinical atherosclerosis (the low-risk stratum, upper bound of CI, 1.2%). No cardiac deaths occurred in the 652 negligible-risk patients who had no clinical atherosclerosis and low atherogenic risk factor profiles.
|
None of the 15 patients with infarctions had unstable angina preoperatively or had surgery within 3 months of a previous infarction. Ten of the 15 infarctions were diagnosed on or before the third postoperative day; three were diagnosed on day 4, one on day 7, and one on day 19. Chest pain was a presenting symptom in only 2 of 15 patients (13%). Three of the 15 (20%) were completely asymptomatic; they would have been missed without the protocol ECGs and enzyme tests. Four (27%) myocardial infarctions were fatal.
Risk Factors for Infarction
The stratification scheme assessed the importance of coronary disease as a risk factor for perioperative infarction. We evaluated other potential risk factors in the combined group of low-, intermediate-, and high-risk patients. Univariate comparisons Table 4 indicate that besides coronary disease, a history of heart failure, previous vascular surgery, and signs of heart failure on the preoperative examination were significantly associated with infarction. Men who had intraoperative hypotension or who had vascular surgery were more likely to have perioperative infarction. Operation time was shorter in men who had infarction, which was due to the disproportionate number of amputations (short procedures) in this group.
|
We used multivariable analysis to test age, race, coronary artery disease, history of myocardial infarction, diabetes, hypertension, stroke, angina, heart failure signs on the preoperative examination, chronic use of ß-blockers, a planned vascular procedure, and planned general anesthesia. Four were found to be independently associated with infarction Table 5: age more than 75 years, the presence of heart failure signs preoperatively, coronary artery disease, and a planned vascular procedure.
|
No infarctions occurred in the 256 low-risk stratum patients. Summary data indicate a fairly high prevalence of chronic medical problems in the stratum, although they seemed not to increase the risk for perioperative infarction. The mean age was 65.5 years ± 6.97 (SD); 52% were white; and 64% were smokers. Five percent had a history of heart failure (from nonischemic causes), and 6% had evidence of heart failure on the preoperative examination. Thirty-seven percent had hypertension, 16% had diabetes, and 36% had another chronic medical illness. The group's average likelihood of a cardiac event within 6 years according to the Framingham risk Equation was 20% ± 4%.
Discussion
|
|---|
|
|
|---|
The overall performance of our risk stratification scheme supports the proposition that coronary disease is the most powerful risk factor for perioperative infarction. This rapid, inexpensive scheme distinguished different levels of risk for perioperative infarction and may be useful in deciding which patients need further evaluation. Coronary disease prevalence, and therefore the risk for perioperative infarction, is negligible in patients who have neither clinical atherosclerosis nor high atherogenic risk factor profiles. Workup of such patients beyond the history and physical examination would not be cost-effective. Neither does a high atherogenic risk factor profile warrant extensive preoperative cardiac evaluation: In 256 such patients in our study, no infarctions occurred. Almost all the infarctions in this study occurred in men whose coronary disease was obvious during the preoperative workup. The rest occurred in men who had peripheral vascular disease without evident coronary disease. About one third of the latter can be expected to have clinically significant occult coronary disease [14]. We found the incidence of perioperative infarction in such patients to be 0.8%. Whether this incidence is high enough to warrant preoperative cardiac workup in these patients requires a riskbenefit analysis beyond the scope of this article. Other data from this study can be used to help decide which patients with coronary or peripheral atherosclerosis would benefit most from additional preoperative testing. Age more than 75, preoperative evidence of heart failure, and a planned vascular operation were independently associated with an increased risk for infarction. Heart failure is a predictor of perioperative complications in some [5] but not all studies [7]. Control of symptoms and signs of heart failure preoperatively is a desirable goal because there are physiologic reasons to believe that doing so may reduce risk for perioperative myocardial infarction. Our finding that patients undergoing vascular surgery are at increased risk for peri-operative infarction is consonant with a growing body of literature [9, 12, 15, 31, 32]. In this study, men with overt coronary disease had 2.7 times the risk for infarction if their operation was a vascular procedure (CI, 0.86 to 8.70; data not shown). Overall, the adjusted odds ratio for vascular surgery compared with nonvascular surgery was 4.3.
This study has several limitations. The preoperative assessment was as standard as possible, but the diagnosis of coronary disease is always imprecise when made clinically. However, our aim was to replicate the circumstances under which preoperative risk evaluation is done in actual practice. Our decision to include chart review patients in the analysis may be challenged on the grounds that substantial misclassification may have occurred on both the risk factors and outcome. On the other hand, we thought that, because of the healthy volunteer effect, excluding them might give an overly optimistic picture of the incidence of infarction. In fact, the incidence was similar in chart review patients, despite the bias toward underdiagnosis. The results of the study should be generalized with caution because we studied only male veterans undergoing surgery at a large urban Veterans Affairs hospital. Such patients may have, on average, poorer health and a higher prevalence of harmful habits. In addition, the clinical prediction logistic model has not been validated prospectively.
Many questions remain about perioperative infarction but the most pressing pertain to risk assessment and prevention. On the basis of our findings, preoperative testing beyond the history, physical examination, and ECG would not have been cost-effective for men in the negligible-, low-, and, some would say, the intermediate-risk strata. Such patients account for 61% (79% if the intermediate stratum is included) of men older than 40 years undergoing major noncardiac surgery at our hospital. But once a patient is classified as high risk, what is the safest, most effective way to reduce the likelihood of perioperative infarction? None of the proposed risk-reducing maneuvers, from the intraoperative use of certain drugs, intraoperative pulmonary artery catheterization, postoperative intensive care, to coronary artery bypass, has been evaluated in a randomized trial. If the incidence of infarction is truly as low as we found in this study, some of the alleged risk-lowering interventions in use today may in fact be more dangerous than doing nothing.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Knapp RB, Topkins MJ, Artusio JF. The cerebrovascular accident and coronary occlusion in anesthesia. JAMA. 1962; 182:106-8.
2. Tarhan S, Moffitt EA, Taylor WF, Guiliani ER. Myocardial infarction after general anesthesia. JAMA. 1972; 220:1451-4.
3. Riles TS, Kopelman I, Imparato AM. Myocardial infarction following carotid endarterectomy: a review of 683 operations. Surgery. 1979; 85:249-52.
4. von Knorring J. Postoperative myocardial infarction: a prospective study in a risk group of surgical patients. Surgery. 1981; 90:55-60.
5. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 297:845-50.
6. Rao TL, Jacobs KH, El-Etr A. Reinfarction following anesthesia in patients with myocardial infarction. Anesthesiology. 1983; 59:499-505.
7. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med. 1990; 323:1781-8.
8. Steen PA, Tinker JH, Tarhan S. Myocardial reinfarction after anesthesia and surgery. JAMA. 1978; 239:2566-70.
9. Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos JA, Cutler BS. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol. 1987; 9:269-76.
10. Detsky AS, Abrahms HB, McLaughlin JR, Drucker DJ, Sasson Z, Johnston N, et al. Predicting cardiac complications in patients undergoing noncardiac surgery. J Gen Intern Med. 1986; 1:211-19.
11. Ashton CM, Lahart CJ, Wray NP. The incidence of perioperative myocardial infarction with transurethral resection of the prostate. J Am Geriatr Soc. 1989; 37:614-8.
12. Morise AP, McDowell DE, Savrin RA, Goodwin CA, Gabrielle OF, Oliver FN, et al. The prediction of cardiac risk in patients undergoing vascular surgery. Am J Med Sci. 1987; 293:150-8.
13. Whittemore AD, Clowes AW, Hechtman HB, Mannick JA. Aortic aneurysm repair. Reduced operative mortality associated with maintenance of optimal cardiac performance. Ann Surg. 1980; 192:414-21.
14. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients. Ann Surg. 1984; 199:223-33.
15. Boucher CA, Brewster DC, Darling RC, Okada RD, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 1985; 312:389-94.
16. Foster ED, Davis KB, Carpenter JA, Abele S, Fray D. Risk of noncardiac operation in patients with defined coronary disease: The Coronary Artery Surgery Study (CASS) registry experience. Ann Thorac Surg. 1986; 41:42-50.
17. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Boston: Wright-PSG, 1982.
18. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med. 1979; 300:1350-8.
19. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol. 1976; 38:46-51.
20. Gordon T, Kannel WB. Coronary Risk Handbook. Estimating Risk of Coronary Heart Disease in Daily Practice. Dallas, TX: American Heart Association; 1983.
21. Salel AF, Fong A, Zelis BS, Miller RR, Borhani NO, Mason DT. Accuracy of numerical coronary profile. N Engl J Med. 1977; 296: 1447-50.
22. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. 2 ed. New York: World Health Organization; 1982:162-5.
23. Mauney FM Jr, Ebert PA, Sabiston DC Jr. Postoperative myocardial infarction: a study of predisposing factors, diagnosis and mortality in a high risk group of surgical patients. Ann Surg. 1970; 172: 497-503.[Medline]
24. Roberts R, Gowda KS, Ludbrook PA, Sobel BE. Specificity of elevated serum MB creatine phosphokinase activity in the diagnosis of acute myocardial infarction. Am J Cardiol. 1975; 36:433-7.
25. Irvin RG, Cobb FR, Roe CR. Acute myocardial infarction and MB creatine phosphokinase. Arch Intern Med. 1980; 140:329-34.
26. Uusitupa M, Pyorala K, Raunio H, Rissanen V, Lampainen E. Sensitivity and specificity of Minnesota Code Q-QS abnormalities in the diagnosis of myocardial infarction verified at autopsy. Am Heart J. 1983; 106:753-7.
27. Seckinger DL, Vazquez A, Rosenthal PK, Mendizibal RC. Cardiac isoenzyme methodology and the diagnosis of acute myocardial infarction. Am J Clin Pathol. 1983; 80:164-9.
28. Righetti A, O'Rourke RA, Schelbert H, Henning H, Hardarson T, Daily PO, et al. Usefulness of preoperative and postoperative Tc-99m (Sn)-pyrophosphate scans in patients with ischemic and valvular heart disease. Am J Cardiol. 1977; 39:43-9.
29. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
30. Driscoll AC, Hobika JH, Etsten BE, Proger S. Clinically unrecognized myocardial infarction following surgery. N Engl J Med. 1961; 264:633-9.
31. Eagle KA, Coley CM, Newell JB, Brewster DC, Darling RC, Strauss HW, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989; 110:859-66.
32. Raby KE, Goldman L, Creager MA, Cook, EF, Weisberg MC, Whittemore AD, et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med. 1989; 321:1296-300.
This article has been cited by other articles:
![]() |
G. Gregoratos Current Guideline-Based Preoperative Evaluation Provides the Best Management of Patients Undergoing Noncardiac Surgery Circulation, June 17, 2008; 117(24): 3134 - 3144. [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation, October 23, 2007; 116(17): e418 - e499. [Full Text] [PDF] |
||||
![]() |
J. Bai, J. Hashimoto, T. Nakahara, T. Suzuki, and A. Kubo Influence of ageing on perioperative cardiac risk in non-cardiac surgery Age Ageing, January 1, 2007; 36(1): 68 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Howard-Alpe, J. W. Sear, and P. Foex Methods of detecting atherosclerosis in non-cardiac surgical patients; the role of biochemical markers Br. J. Anaesth., December 1, 2006; 97(6): 758 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Adesanya, J. A. de Lemos, N. B. Greilich, and C. W. Whitten Management of perioperative myocardial infarction in noncardiac surgical patients. Chest, August 1, 2006; 130(2): 584 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Maynard, E. Lowy, J. Rumsfeld, A. E. Sales, H. Sun, B. Kopjar, B. Fleming, R. L. Jesse, R. Rusch, and S. D. Fihn The prevalence and outcomes of in-hospital acute myocardial infarction in the department of veterans affairs health system. Arch Intern Med, July 10, 2006; 166(13): 1410 - 1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kaw, F. Michota, A. Jaffer, S. Ghamande, D. Auckley, and J. Golish Unrecognized Sleep Apnea in the Surgical Patient: Implications for the Perioperative Setting Chest, January 1, 2006; 129(1): 198 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Redelmeier, D. Scales, and A. Kopp {beta} blockers for elective surgery in elderly patients: population based, retrospective cohort study BMJ, October 22, 2005; 331(7522): 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.J. Devereaux, L. Goldman, S. Yusuf, K. Gilbert, K. Leslie, and G. H. Guyatt Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review Can. Med. Assoc. J., September 27, 2005; 173(7): 779 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.J. Devereaux, L. Goldman, D. J. Cook, K. Gilbert, K. Leslie, and G. H. Guyatt Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk Can. Med. Assoc. J., September 13, 2005; 173(6): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. McCrath, E. Cerboni, R. J. Frumento, A. L. Hirsh, and E. Bennett-Guerrero Thromboelastography Maximum Amplitude Predicts Postoperative Thrombotic Complications Including Myocardial Infarction Anesth. Analg., June 1, 2005; 100(6): 1576 - 1583. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W. HERMAN, J. L. KONZELMAN JR., and L. M. PRISANT New national guidelines on hypertension: A summary for dentistry J Am Dent Assoc, May 1, 2004; 135(5): 576 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Howell, J. W. Sear, and P. Foex Hypertension, hypertensive heart disease and perioperative cardiac risk{dagger} Br. J. Anaesth., April 1, 2004; 92(4): 570 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filipovic, R. Jeger, C. Probst, T. Girard, M. Pfisterer, L. Gurke, K. Skarvan, and M. D. Seeberger Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease J. Am. Coll. Cardiol., November 19, 2003; 42(10): 1767 - 1776. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Landesberg, V. Shatz, I. Akopnik, Y. G. Wolf, M. Mayer, Y. Berlatzky, C. Weissman, and M. Mosseri Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1547 - 1554. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Licker, G. Khatchatourian, A. Schweizer, M. Bednarkiewicz, D. Tassaux, and C. Chevalley The Impact of a Cardioprotective Protocol on the Incidence of Cardiac Complications After Aortic Abdominal Surgery Anesth. Analg., December 1, 2002; 95(6): 1525 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-G. Chassot, A. Delabays, and D. R. Spahn Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery Br. J. Anaesth., November 1, 2002; 89(5): 747 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Barone, M. B. Bull, E. H. Cussatti, K. D. Miller, and J. B. Tucker Perioperative Myocardial Infarction in Low-Risk Patients Undergoing Noncardiac Surgery Is Associated With Intraoperative Hypotension J Intensive Care Med, September 1, 2002; 17(5): 250 - 255. [Abstract] [PDF] |
||||
![]() |
A. D. Auerbach and L. Goldman {beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review JAMA, March 20, 2002; 287(11): 1435 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Auerbach and L. Goldman {beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Clinical Applications JAMA, March 20, 2002; 287(11): 1445 - 1447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Eagle, P. B. Berger, H. Calkins, B. R. Chaitman, G. A. Ewy, K. E. Fleischmann, L. A. Fleisher, J. B. Froehlich, R. J. Gusberg, J. A. Leppo, et al. ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery--Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation, March 12, 2002; 105(10): 1257 - 1267. [Full Text] [PDF] |
||||
![]() |
K. A. Eagle, P. B. Berger, H. Calkins, B. R. Chaitman, G. A. Ewy, K. E. Fleischmann, L. A. Fleisher, J. B. Froehlich, R. J. Gusberg, J. A. Leppo, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) J. Am. Coll. Cardiol., February 6, 2002; 39(3): 542 - 553. [Full Text] [PDF] |
||||
![]() |
V. A. Lawrence Predicting Postoperative Pulmonary Complications: The Sleeping Giant Stirs Ann Intern Med, November 20, 2001; 135(10): 919 - 921. [Full Text] [PDF] |
||||
![]() |
H.-J. Priebe The aged cardiovascular risk patient Br. J. Anaesth., November 1, 2000; 85(5): 763 - 778. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. ROSTAND Coronary Heart Disease in Chronic Renal Insufficiency: Some Management Considerations J. Am. Soc. Nephrol., October 1, 2000; 11(10): 1948 - 1956. [Full Text] |
||||
![]() |
K. Gilbert, B. J. Larocque, and L. T. Patrick Prospective Evaluation of Cardiac Risk Indices for Patients Undergoing Noncardiac Surgery Ann Intern Med, September 5, 2000; 133(5): 356 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C Krupski, M. R Nehler, T. A Whitehill, R. C Lawson, P. K Strecker, and W. R Hiatt Negative impact of cardiac evaluation before vascular surgery Vascular Medicine, February 1, 2000; 5(1): 3 - 9. [Abstract] [PDF] |
||||
![]() |
W. C. Krupski Expert Commentary Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 2000; 12(2): 43 - 48. [PDF] |
||||
![]() |
R. Sicari, A. Ripoli, E. Picano, A. Djordjevic-Dikic, R. Di Giovanbattista, G. Minardi, S. Matskeplishvili, S. Ambatiello, G. Pulignano, M. Accarino, et al. Perioperative Prognostic Value of Dipyridamole Echocardiography in Vascular Surgery : A Large-Scale Multicenter Study in 509 Patients Circulation, November 9, 1999; 100(90002): II-269 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Reilly, M. J. McNeely, D. Doerner, D. L. Greenberg, T. O. Staiger, M. J. Geist, P. A. Vedovatti, J. E. Coffey, M. W. Mora, T. R. Johnson, et al. Self-reported Exercise Tolerance and the Risk of Serious Perioperative Complications Arch Intern Med, October 11, 1999; 159(18): 2185 - 2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Posner, G. A. Van Norman, and V. Chan Adverse Cardiac Outcomes After Noncardiac Surgery in Patients with Prior Percutaneous Transluminal Coronary Angioplasty Anesth. Analg., September 1, 1999; 89(3): 553 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Hollenberg Preoperative Cardiac Risk Assessment Chest, May 1, 1999; 115(suppl_2): 51S - 57S. [Abstract] [Full Text] |